Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized controlled trials

Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized controlled trials

Introduction: This study aimed to assess the tumor risk of finerenone in individuals with type 2 diabetes mellitus (T2DM) aggravated by chronic kidney disease (CKD).Methods: A thorough search in the OVID Medline, OVID EMBASE, and Cochrane Library databases from their creation through 2 November 2022...

Full description

Bibliographic Details
Main Authors: Yue Du, Gui Cao, Linlin Gu, Yuehong Chen, Jingyu Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
finerenone
T2DM
chronic kidney disease
tumor
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1237583/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1237583/full

Similar Items